{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T20:48:00Z","timestamp":1700513280833},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.medcli.2016.09.050","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T02:01:00Z","timestamp":1482890460000},"page":"243-249","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pron\u00f3stico similar de los linfomas transformados y los linfomas difusos de c\u00e9lulas B grandes de novo en pacientes tratados con inmunoquimioterapia"],"prefix":"10.1016","volume":"148","author":[{"given":"Marc","family":"Sorigue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Joao","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Manuel","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Mate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evarist","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Tom\u00e1s","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep-Maria","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2016.09.050_bib0180","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0185","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0190","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/10428194.2011.631637","article-title":"High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era","volume":"53","author":"Ban-Hoefen","year":"2012","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.medcli.2016.09.050_bib0195","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/annonc\/mdt029","article-title":"Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation","volume":"24","author":"Villa","year":"2013","journal-title":"Ann Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0200","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00277-013-1991-y","article-title":"Survival of patients with transformed lymphoma in the rituximab era","volume":"93","author":"Guirguis","year":"2014","journal-title":"Ann Hematol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0205","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1023\/A:1008349427337","article-title":"High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients form a single centre","volume":"9","author":"Foran","year":"1998","journal-title":"Ann Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0210","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.2001.19.3.727","article-title":"High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: A case-matched study from the European Bone Marrow Transplant Registry","volume":"19","author":"Williams","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0215","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: A report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource","volume":"31","author":"Link","year":"2013","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0220","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1080\/10428190903128652","article-title":"High rate of survival in transformed lymphoma after autologous stem cell transplant: Pathologic analysis and comparison with de novo diffuse large B-cell lymphoma","volume":"50","author":"Smith","year":"2009","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.medcli.2016.09.050_bib0225","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428194.2013.861067","article-title":"Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment","volume":"55","author":"Lenglet","year":"2014","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.medcli.2016.09.050_bib0230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1634\/theoncologist.2012-0251","article-title":"Treatment of splenic marginal zone lymphoma with rituximab monotherapy: Progress report and comparison with splenectomy","volume":"18","author":"Kalpadakis","year":"2013","journal-title":"Oncologist."},{"key":"10.1016\/j.medcli.2016.09.050_bib0235","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0240","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1200\/JCO.2010.32.7577","article-title":"Transformation of indolent B-cell lymphomas","volume":"29","author":"Montoto","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0245","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3748\/wjg.v21.i13.3773","article-title":"Helicobacter pylori eradication in gastric diffuse large B cell lymphoma","volume":"21","author":"Paydas","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0250","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1182\/blood-2013-11-516229","article-title":"How we treat Richter syndrome","volume":"123","author":"Parikh","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.09.050_bib0255","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2016.09.050_bib0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.09.050_bib0265","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2007.15.9277","article-title":"Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma","volume":"26","author":"Fu","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0270","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2006-09-047068","article-title":"Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy","volume":"109","author":"Nyman","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.09.050_bib0275","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1349-7006.2008.00873.x","article-title":"Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: Morphological, immunohistochemical, and FISH analyses","volume":"99","author":"Maeshima","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.medcli.2016.09.050_bib0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2559.2005.02068.x","article-title":"Aggressive B-cell lymphomas: A review based on the workshop of the XI Meeting of the European Association for Haematopathology","volume":"46","author":"Leoncini","year":"2005","journal-title":"Histopathology."},{"key":"10.1016\/j.medcli.2016.09.050_bib0285","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.medcli.2016.09.050_bib0290","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet."},{"key":"10.1016\/j.medcli.2016.09.050_bib0295","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0300","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/cncr.27918","article-title":"Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)","volume":"119","author":"Ribera","year":"2013","journal-title":"Cancer."},{"key":"10.1016\/j.medcli.2016.09.050_bib0305","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2006.06439.x","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms","volume":"136","author":"Davies","year":"2007","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0310","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","article-title":"Outcomes of transformed follicular lymphoma in the modern era: A report from the National LymphoCare Study (NLCS)","volume":"126","author":"Wagner-Johnston","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.09.050_bib0315","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1200\/JCO.1995.13.7.1726","article-title":"Long-term survival after histologic transformation of low-grade follicular lymphoma","volume":"13","author":"Yuen","year":"1995","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0320","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00277-015-2303-5","article-title":"Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: A retrospective multicentre analysis","volume":"94","author":"Lerch","year":"2015","journal-title":"Ann Hematol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0325","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3109\/10428194.2013.871632","article-title":"High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era","volume":"55","author":"Blaker","year":"2014","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.medcli.2016.09.050_bib0330","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clml.2016.03.014","article-title":"Consolidative radioimmunotherapy after chemoimmunotherapy in patients with histologic transformation of indolent non-Hodgkin lymphoma","volume":"16","author":"Reagan","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.medcli.2016.09.050_bib0335","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.2012.44.0693","article-title":"Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: A report of the Canadian blood and marrow transplant group","volume":"31","author":"Villa","year":"2013","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0340","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2011.08969.x","article-title":"Guidelines on the investigation and management of follicular lymphoma","volume":"156","author":"McNamara","year":"2012","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2016.09.050_bib0345","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1182\/blood-2008-01-136242","article-title":"Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab","volume":"111","author":"Khouri","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.09.050_bib0350","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S1470-2045(15)00005-4","article-title":"Double-hit and double-protein-expression lymphomas: Aggressive and refractory lymphomas","volume":"16","author":"Sarkozy","year":"2015","journal-title":"Lancet Oncol."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531630611X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531630611X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T13:51:19Z","timestamp":1536155479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577531630611X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S002577531630611X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2016.09.050","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pron\u00f3stico similar de los linfomas transformados y los linfomas difusos de c\u00e9lulas B grandes de novo en pacientes tratados con inmunoquimioterapia","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2016.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}